Concepedia

Author

Kenneth Algazy

University of Pennsylvania

Also Known As

K Algazy, K. A. Algazy, K. Algazy, KENNETH ALGAZY, Kenneth Algazy

24

Publications

373

Citations

13

H-Index

40

Concepts

All Affiliations

University of PennsylvaniaUniversity of Pennsylvania Health SystemFox Chase Cancer Center
KA

About

Kenneth Algazy is an author at University of Pennsylvania specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

208

2

Health Sciences

2

2

63

3

Public Health

1

1

22

4

Emergency Medicine

1

1

22

5

Gastroenterology

1

1

19

Kenneth Algazy

×

13

Publications

363

Citations

13

H-Index

YearCitations

A Phase I Study of SPI-077 (Stealth® Liposomal Cisplatin) Concurrent with Radiation Therapy for Locally Advanced Head and Neck Cancer

David I. Rosenthal, Sue S. Yom, Li Liu,

Investigational New Drugs

2002

48

Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days.

James Stevenson, Weijing Sun, Maryann Gallagher,

PubMed

2002

44

Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer

James Stevenson, Maryann Redlinger, Leo A. J. Kluijtmans,

Journal of Clinical Oncology

2001

43

A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m<sup>2</sup>for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Matthew G. Fury, Eric J. Sherman, Donna Lisa,

Journal of the National Comprehensive Cancer Network

2012

40

Effects of bortezomib (PS-341) on NF-κB activation in peripheral blood mononuclear cells (PBMCs) of advanced non-small lung cancer (NSCLC) patients: A phase II/pharmacodynamic trial

James Stevenson, Chu Won Nho, Steven W. Johnson,

Journal of Clinical Oncology

2004

31

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

Jessica R. Bauman, Corey J. Langer, Harry Quon,

Experimental and Therapeutic Medicine

2013

30

A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors

Weijing Sun, James Stevenson, Maryann Gallagher,

Cancer

2001

24

Thrombolysis of acute or subacute nonembolic arterial thrombosis

Frederick A. Reichle, Narasimha Rao, Kam H.Y. Chang,

Journal of Surgical Research

1977

22

Endoscopic diagnosis of eosinophilic gastritis

Farhad Navab, Martin S. Kleinman, Kenneth Algazy,

Gastrointestinal Endoscopy

1972

19

Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): The Expanded Access Protocol Experience at the University of Pennsylvania

Maria Luisa Veronese, Kenneth Algazy, Lisa Bearn,

Cancer Investigation

2005

18

Page 1